Why is OpGen Inc. (OPGN) down -34.43% from the day 1 this year?

At the end of the latest market close, OpGen Inc. (OPGN) was valued at $2.40. In that particular session, Stock kicked-off at the price of $2.38 while reaching the peak value of $2.44 and lowest value recorded on the day was $2.35. The stock current value is $2.48.

Recently in News on October 15, 2020, OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020. OpGen takes strategic steps to expand the Unyvero platform and product pipeline, to focus on the pending Acuitas AMR Gene Panel (isolates) FDA clearance and expects to invest significantly in bioinformatics. You can read further details here

My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<


OpGen Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.76 on 03/16/20, with the lowest value was $1.11 for the same time period, recorded on 01/03/20.

OpGen Inc. (OPGN) full year performance was -34.43%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, OpGen Inc. shares are logging -64.82% during the 52-week period from high price, and 169.57% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.92 and $7.05.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 551014 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the OpGen Inc. (OPGN) recorded performance in the market was 112.39%, having the revenues showcasing 14.29% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 47.69M, as it employees total of 38 workers.

Market experts do have their say about OpGen Inc. (OPGN)

During the last month, 0 analysts gave the OpGen Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.21, with a change in the price was noted +0.51. In a similar fashion, OpGen Inc. posted a movement of +25.76% for the period of last 100 days, recording 4,887,057 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for OPGN is recording 1.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.90.

Technical breakdown of OpGen Inc. (OPGN)

Raw Stochastic average of OpGen Inc. in the period of last 50 days is set at 35.72%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 87.76%. In the last 20 days, the company’s Stochastic %K was 78.08% and its Stochastic %D was recorded 75.10%.

Bearing in mind the latest performance of OpGen Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 112.39%. Additionally, trading for the stock in the period of the last six months notably improved by 8.60%, alongside a downfall of -34.43% for the period of the last 12 months. The shares increased approximately by 0.42% in the 7-day charts and went down by 18.23% in the period of the last 30 days. Common stock shares were driven by 14.29% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the Investchronicle.com pre-market morning brief 100% free